Clinical Trials Browser

Phase 2 × Advanced Breast Carcinoma × trastuzumab biosimilar HLX02 × Clear all

NCT03179904 2026-02-24

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Phase 2 Active not recruiting

17 enrolled 10 charts

Advanced Breast Carcinoma